<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To compare obstetric and perinatal outcomes in women with Type 1 and Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and relate these to maternal risk factors </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Prospective cohort study of 682 consecutive diabetic pregnancies in East Anglia during 2006-2009 </plain></SENT>
<SENT sid="2" pm="."><plain>Relationships between <z:e sem="disease" ids="C1705254" disease_type="Disease or Syndrome" abbrv="">congenital malformation</z:e>, perinatal mortality and perinatal morbidity (<z:hpo ids='HP_0001520'>large for gestational age</z:hpo>, <z:hpo ids='HP_0001622'>preterm delivery</z:hpo>, neonatal care) with maternal age, parity, ethnicity, glycaemic control, <z:hpo ids='HP_0001513'>obesity</z:hpo> and social disadvantage were examined using bivariable and multivariate models </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: There were 408 (59.8%) Type 1 and 274 (40.2%) Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> pregnancies </plain></SENT>
<SENT sid="4" pm="."><plain>Women with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> were older (P &lt; 0.001), heavier (P &lt; 0.0001), more frequently multiparous (P &lt; 0.001), more ethnically diverse (p &lt; 0.0001) and more socially disadvantaged (P = 0.0004) </plain></SENT>
<SENT sid="5" pm="."><plain>Although women with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> had shorter duration of <z:mp ids='MP_0002055'>diabetes</z:mp> (P &lt; 0.0001) and better pre-conception glycaemic control [HbA(1c) 52 mmol/mol (6.9%) Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> vs. 63 mmol/l (7.9%) Type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>; p &lt; 0.0001), rates of <z:e sem="disease" ids="C1705254" disease_type="Disease or Syndrome" abbrv="">congenital malformation</z:e> and perinatal mortality were comparable </plain></SENT>
<SENT sid="6" pm="."><plain>Women with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> had fewer <z:hpo ids='HP_0001520'>large-for-gestational-age</z:hpo> infants (37.6 vs. 52.9%, P &lt; 0.0008), fewer <z:hpo ids='HP_0001622'>preterm deliveries</z:hpo> (17.5 vs. 37.1%, P &lt; 0.0001) and their offspring had fewer neonatal care admissions (29.8 vs. 43.2%, P = 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>Third trimester HbA(1c) (OR 1.35, 95% CI 1.09-1.67, P = 0.006) and social disadvantage (OR 0.80, 95% CI 0.67-0.98; P = 0.03) were risk factors for <z:hpo ids='HP_0001520'>large for gestational age</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Despite increased age, parity, <z:hpo ids='HP_0001513'>obesity</z:hpo> and social disadvantage, women with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> had better glycaemic control, fewer <z:hpo ids='HP_0001520'>large-for-gestational-age</z:hpo> infants, fewer <z:hpo ids='HP_0001622'>preterm deliveries</z:hpo> and fewer neonatal care admissions </plain></SENT>
<SENT sid="9" pm="."><plain>Better tools are needed to improve glycaemic control and reduce the rates of <z:hpo ids='HP_0001520'>large for gestational age</z:hpo>, particularly in Type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>